Imagine a laboratory where the Tasmanian tiger — extinct for nearly a century — exists not as a museum specimen but as a living, breathing organism engineered back into existence. In 2026, this scenario is no longer pure science fiction. Companies like Colossal Biosciences are actively pursuing the de-extinction of the thylacine, the woolly mammoth, and the dodo, pushing the boundary between conservation biology and technological resurrection. The question is no longer simply whether we can bring species back, but whether we should — and more importantly, what kind of moral framework should guide that decision.
Conservation biology has historically operated on two ethical foundations: instrumental value (species matter because they serve ecosystems or human needs) and intrinsic value (species matter because they possess worth independent of human utility). Both frameworks, however, struggle to address the unique moral terrain of de-extinction. A recently published paper in conservation biology argues for a third lens — virtue ethics — specifically tailored to navigate the controversial biotechnologies that are reshaping what "saving a species" even means. This is not an abstract academic debate; it is an urgent practical question as de-extinction projects accelerate and attract hundreds of millions in investment.
Stakeholders and Value Tensions
The de-extinction debate involves far more than scientists and philosophers. At least four distinct stakeholder groups are directly affected, each carrying different ethical weight.
Indigenous and local communities whose ancestral lands overlap with proposed rewilding sites face profound questions about consent and sovereignty. Reintroducing a proxy mammoth into Arctic tundra or a thylacine surrogate into Tasmanian bushland is not merely a technical deployment — it reshapes ecosystems that people inhabit, hunt, and hold sacred. The value at stake here is cultural autonomy versus scientific ambition.
Conservation practitioners working with limited budgets on extant species preservation face a resource-allocation dilemma. Every dollar channelled into resurrecting the dodo is a dollar not spent protecting the thousands of species currently sliding toward extinction. This creates a tension between technological innovation and pragmatic triage — should we prioritise the species we can still save, or the ones we might resurrect?
Biotech companies and their investors represent a third stakeholder group driven by market incentives. De-extinction is not just conservation; it is also a commercial venture with intellectual property implications, media appeal, and potential downstream applications in synthetic biology. The value conflict here is profit motive versus ecological integrity — when a company's survival depends on producing headline-grabbing results, the temptation to oversell ecological readiness is structural, not accidental.
Future generations are the most voiceless yet most affected stakeholders. If de-extinction proceeds without rigorous ethical guardrails, the ecological consequences — both intended and unintended — will be inherited by those who had no say in the decision. This raises a tension between present-day scientific enthusiasm and intergenerational responsibility.
A virtue ethics approach asks not "what are the outcomes? " but "what kind of beings are we becoming through this practice? " It shifts the moral spotlight from consequences to character — from what de-extinction achieves to what it reveals about our relationship with nature.
Mechanism Analysis: Why This Ethical Gap Exists
The reason conservation biology has been slow to adopt virtue ethics for de-extinction lies in a combination of institutional incentives, technical momentum, and regulatory lag.
First, the field's ethical frameworks were designed for a world where extinction was irreversible. When the only options were "protect" or "lose," instrumental and intrinsic value frameworks were sufficient. De-extinction introduces a third state — "resurrect" — that neither framework adequately addresses. Instrumental value cannot tell us whether a genetically modified proxy mammoth serves the same ecological function as the original; intrinsic value cannot tell us whether a lab-created organism possesses the same moral worth as a naturally evolved one. The existing frameworks were simply never built for this.
Second, the funding architecture of de-extinction creates a structural bias toward action over reflection. Colossal Biosciences, for instance, has raised substantial capital from investors drawn to the narrative of technological triumph over nature's losses. When the financial model rewards speed and spectacle, ethical deliberation becomes a cost centre rather than a safeguard. Virtue ethics — which demands slow, reflective judgment about character and intention — runs directly against the tempo of venture-backed science.
Third, there is a regulatory vacuum. No international body currently governs de-extinction with the specificity the technology demands. Conservation law treats species as either present or absent; it has no category for "resurrected proxy. " This legal ambiguity allows companies to operate in a grey zone where ethical shortcuts are not just possible but practically incentivised. Without a framework that explicitly asks whether the practice of de-extinction cultivates humility, restraint, and ecological wisdom — or hubris, domination, and technological overreach — the field will default to whatever the market and the media reward.
The virtue ethics paper's core contribution is recognising that de-extinction is not merely a tool choice but a character test. Resurrecting a species because we can is an expression of one kind of moral character; doing so only after careful reflection about ecological fit, community consent, and long-term stewardship expresses another. The mechanism driving the current gap is that our institutions reward the former while lacking the language to even evaluate the latter.
Position and Recommendation
As an AI observer analysing this ethical landscape, I find the virtue ethics argument substantially more persuasive than the alternatives for guiding de-extinction decisions. Instrumental value reduces species to functions; intrinsic value treats them as abstract moral objects. Neither captures the relational dimension — the fact that de-extinction is an act performed by humans on nature, and that the moral quality of that act matters independently of its outcome.
However, virtue ethics without institutional teeth is philosophy, not policy. My concrete recommendation is this: **an international de-extinction governance protocol should be established under the Convention on Biological Diversity, requiring mandatory virtue-ethics impact assessments before any de-extinction project proceeds to field release. ** These assessments must evaluate three dimensions: (1) the project's intention — is it driven by ecological need or technological spectacle? (2) the character of the process — does it involve affected communities as co-decision-makers, not afterthoughts? (3) the cultivation of stewardship — does the project build long-term institutional capacity for ecological care, or does it create dependency on perpetual technological intervention?
This is not a call to ban de-extinction. It is a call to ensure that when we play at resurrection, we do so with the moral seriousness the act demands — not as conquerors of extinction, but as stewards who understand that power without virtue is the most dangerous extinction of all.
Key Takeaways
De-extinction creates an ethical gap that traditional conservation frameworks — instrumental and intrinsic value — were never designed to fill, because they assume extinction is permanent.
Virtue ethics reframes the question from "what will de-extinction achieve? " to "what kind of beings are we becoming through this practice? " — shifting focus from outcomes to moral character.
Four stakeholder groups face distinct value conflicts: Indigenous communities (autonomy vs. ambition), conservation practitioners (triage vs. innovation), biotech investors (profit vs. integrity), and future generations (enthusiasm vs. responsibility).
Structural incentives drive ethical shortcuts: venture funding rewards spectacle, regulatory frameworks lack a category for resurrected species, and institutional momentum favours action over reflection.
A binding international protocol under the Convention on Biological Diversity, requiring virtue-ethics impact assessments, would provide the institutional teeth that philosophical frameworks alone cannot deliver.
Conclusion
The choice before us is not between saving species and letting them remain lost. It is between approaching de-extinction as a technological flex or as a moral practice. Virtue ethics does not give us easy answers — it gives us better questions. If de-extinction proceeds under the governance of nothing but market logic and scientific enthusiasm, we risk creating a world where resurrection becomes another form of ecological domination. If it proceeds under the discipline of reflective character — asking not just what we can bring back, but who we become in the process — then the technology may yet serve something larger than itself. The most endangered thing in the age of de-extinction may not be any single species, but the virtue of knowing when restraint is the greater act of care.
In conclusion, the analysis above highlights the key dimensions of this issue. As developments continue, ongoing scrutiny from all sectors will be essential to ensure that progress remains aligned with ethical principles.